Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma is a research paper published in Cancer & Metabolism (2024). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: 5T32CA140044-13
National Cancer Institute
Grant: F32CA260735
National Cancer Institute
Grant: K08CA234416
Medical School, University of Michigan
Grant: U083054
National Institutes of Health
Grant: R01CA240515
National Institute of Neurological Disorders and Stroke
Grant: R21NS123879-01
NINDS NIH HHS
Grant: R01 NS119231
NCI NIH HHS
Grant: R01 CA261926
NINDS NIH HHS
Grant: R01 NS129123
NCI NIH HHS
Grant: R37 CA258346
NINDS NIH HHS
Grant: R01 NS110572
NINDS NIH HHS
Grant: R01 NS127799
NINDS NIH HHS
Grant: R21 NS123879
NCI NIH HHS
Grant: T32 CA140044
National Institutes of Health
Grant: 1F32CA260735-01
Targeting purine biosynthesis to radiosensitize glioblastoma
National Institutes of Health
Grant: 5T32CA140044-02
Advanced Proteome Informatics of Cancer
National Institutes of Health
Grant: 5R01NS122536-03
Novel nano-vaccine technology for inducing immunity against gliomas
National Institutes of Health
Grant: 5R01CA240515-04
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
National Institutes of Health
Grant: 5R37NS094804-06
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
National Institutes of Health
Grant: 3P30CA046592-31S7
Cancer Center Support Grant 2018-2023
National Institutes of Health
Grant: 5R37CA258346-03
Targeting Nucleotide Metabolism to Overcome Therapy Resistance in Glioblastoma
National Institutes of Health
Grant: 3R01NS124167-04S1
Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics
National Institutes of Health
Grant: 5K08CA234416-05
De Novo Nucleotide Synthesis as a Mediator of Radiation Resistance and a Therapeutic Target in Glioblastoma
National Institutes of Health
Grant: 1R21NS123879-01
Chemo-immunotherapy strategy for pediatric high grade glioma
National Institutes of Health
Grant: 3R01NS105556-03S1
Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics
National Institutes of Health
Grant: 5T32CA140044-12
Proteogenomics of Cancer Training Program
National Institutes of Health
Grant: 5R01NS129123-03
Inhibition of wild-type IDH1 as a ferroptosis-inducing therapeutic approach for the treatment of malignant glioma.
Alex's Lemonade Stand Foundation for Childhood Cancer
Rogel Cancer Center, University of Michigan
Ivy Glioblastoma Foundation
Damon Runyon Cancer Research Foundation
Forbes Institute for Cancer Discovery
Smiles for Sophie Forever Foundation
Pediatric Brain Tumor Foundation
Sontag Foundation
Department of Neurosurgery, University of Michigan, United States
Ian's Friends Foundation
ChadTough Defeat DIPG Foundation
Leah's Happy Hearts
FWCI
3.32
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals